Cardiac point of care testing: A focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms

Clinical Biochemistry

Volumn 42, Issue 3, 2009, Pages 150-157

  Christenson, Robert H ^a   Azzazy, Hassan M E ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b AMERICAN UNIVERSITY IN CAIRO   (Egypt)

Author keywords

Acute coronary syndromes; Cardiac markers; Cardiac troponin; Guidelines; Myocardial infarction; Point of care; Risk stratification

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; DISEASE MARKER; FLUOROMETRY; HUMAN; LABORATORY TEST; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; POINT-OF-CARE SYSTEMS; PRACTICE GUIDELINES AS TOPIC;

EID: 58349095343     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.09.105     Document Type: Review

References (30)

1. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin. Chem. 53 (2007) 552-574
2. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36 (2000) 959-969
3. Thygesen K., Alpert J.S., White, and H.D. Joint ESC/ACC/AHA/WHF task force for the redefinition of myocardial infarction. Circulation 116 (2007) 2634-2653
4. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J. Am. Coll. Cardiol. 40 (2002) 1366-1374
5. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-171
6. Weissberg P.L. Atherosclerosis involves more than just lipids: plaque dynamics. E. Heart. J. Suppl. 1 Suppl T (1999) T13-T18
7. Apple F.S., Wu A.H., Jaffe A.S., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. Clin. Biochem. 41 (2008) 222-226
8. Azzazy H.M., and Christenson R.H. Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing?. Clin. Biochem. 35 (2002) 13-27
9. Eggers K.M., Oldgren J., Nordenskjold A., and Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am. Heart. J. 148 (2004) 574-581
10. Newby L.K., Storrow A.B., Gibler W.B., et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 103 (2001) 1832-1837
11. Tang W.H., Francis G.S., Morrow D.A., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin. Biochem. 41 (2008) 210-221
12. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
13. Apple F.S., Wu A.H., Mair J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin. Chem. 51 (2005) 810-824
14. Novis D.A., Jones B.A., Dale J.C., Walsh M.K., and College of American Pathologists. Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch. Pathol. Lab. Med. 128 (2004) 158-164
15. Apple F.S., Parvin C.A., Buechler K.F., Christenson R.H., Wu A.H., and Jaffe A.S. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin. Chem. 51 (2005) 2198-2200
16. Lee-Lewandrowski E., Corboy D., Lewandrowski K., Sinclair J., McDermot S., and Benzer T.I. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch. Pathol. Lab. Med. 127 (2003) 456-460
17. Di Serio F., Lovero R., Leone M., et al. Integration between the tele-cardiology unit and the central laboratory: methodological and clinical evaluation of point-of-care testing cardiac marker in the ambulance. Clin. Chem. Lab. Med. 44 (2006) 768-773
18. Kost G.J., and Tran N.K. Point-of-care testing and cardiac biomarkers: the standard of care and vision for chest pain centers. Cardiol. Clin. 23 (2005) 467-490 vi
19. Storrow A.B., Lindsell C.J., Collins S.P., et al. Emergency department multimarker point-of-care testing reduces time to cardiac marker results without loss of diagnostic accuracy. Point of Care 5 (2006) 132-136
20. REACTT. Evaluation of a bedside whole-blood rapid troponin T assay in the emergency department. Rapid Evaluation by Assay of Cardiac Troponin T (REACTT) Investigators Study Group. Acad Emerg Med 4 (1997) 1018-1024
21. Sieck S. The evolution of a new standard of hospital care: paradigm shift to the emergency department and the role of point-of-care testing. Point of Care 5 (2006) 2-5
22. Morrow D.A. Evidence-based decision limits for cardiac troponin: low-level elevation and prognosis. Am. Heart. J. 148 (2004) 739-742
23. Pham M.X., Whooley M.A., Evans Jr. G.T., et al. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Am. Heart. J. 148 (2004) 776-782
24. Pope J.H., Aufderheide T.P., Ruthazer R., et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N. Engl. J. Med. 342 (2000) 1163-1170
25. Storrow A.B., and Gibler W.B. Chest pain centers: diagnosis of acute coronary syndromes. Ann. Emerg. Med. 35 (2000) 449-461
26. Bahr R.D., Leino E.V., and Christenson R.H. Prodromal unstable angina in acute myocardial infarction: prognostic value of short- and long-term outcome and predictor of infarct size. Am. Heart J. 140 (2000) 126-133
27. Cohn P.F. Silent myocardial ischemia: an update. Adv. Intern. Med. 34 (1989) 377-392
28. Apple F.S., Chung A.Y., Kogut M.E., Bubany S., and Murakami M.M. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin. Chim. Acta 370 (2006) 191-195
29. Singer A.J., Ardise J., Gulla J., and Cangro J. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann. Emerg. Med. 45 (2005) 587-591
30. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute cardiac disease. The present and the future. J. Am. Coll. Cardiol. 48 (2006) 1-11